In-Depth 2024 Breast Cancer Monoclonal Antibodies Market Analysis: Growth, Share, and Emerging Trends
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
2024-2033 Breast Cancer Monoclonal Antibodies Market Growth Rate: What’s the Forecast?
The market size for breast cancer monoclonal antibodies has seen significant growth in the recent past. Starting from $18.97 billion in the year 2023, it is expected to further expand and reach $20.18 billion in 2024, exhibiting a compound annual growth rate (CAGR) of 6.4%. This consistent rise in the historical period is a result of increased rates of breast cancer occurrences, growing awareness regarding monoclonal antibodies for breast cancer, escalating proof of clinical effectiveness, and patient demand.
The market for monoclonal antibodies targeting breast cancer is anticipated to experience significant growth in the coming years. By 2028, it’s projected to reach $27.8 billion, with a compound annual growth rate (CAGR) of 8.3%. Factors contributing to this growth during the forecast period include emerging targets, biosimilars, combination therapies, a rising global incidence, an aging population, and personalized medicine. Key trends forecasted for this period comprise advancements in early breast cancer detection, the integration of immunotherapy, the use of liquid biopsies and companion diagnostics, along with adjuvant and neoadjuvant therapies, and increased focus on long-term survivorship support.
Claim Your Free Sample of the Global Breast Cancer Monoclonal Antibodies Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=3450&type=smp
What Drivers Are Accelerating the Growth of the breast cancer monoclonal antibodies Market?
The breast cancer monoclonal antibody market is predicted to expand due to the increasing occurrences of breast cancer. For example, the American Cancer Society, a nonprofit cancer advocacy organization in the US, reported that the occurrences of breast cancer escalated from 284,200 cases in 2021 to 300,590 cases in 2023, indicating a growth of 5.76% in January 2023. Consequently, the global upsurge of breast cancer is anticipated to propel the growth of the breast cancer monoclonal antibody market.
What Key Segments Can Be Identified in the Breast Cancer Monoclonal Antibodies Market?
1) By Product: Naked Mabs, Conjugated Mabs
2) By Treatment: Chemotherapy, Surgery & Radiation Therapy, Targeted Therapy, Biologic Therapy, Hormone Therapy
3) By End-User: Hospitals, Retail Pharmacies
What Trends Are On the Rise in the Breast Cancer Monoclonal Antibodies Market?
Firms in the sector of breast cancer monoclonal antibodies, are channeling resources into targeted and combination therapies. These new treatment approaches have been shown to be more effective and reduce toxicity when compared to traditional treatments. Targeted cancer therapies are effectively comprised of drugs or substances designed to hamper cancer growth by interacting with molecules that primarily play a role in cancer cell progression over normal cell activity. The purpose of such treatments is to eradicate cancer cells without causing harm to normal cells. As this therapy concentrates on cellular changes specific to cancer, it could potentially be more effective than conventional chemotherapy and radiotherapy. Combination therapy applies a treatment methodology where two or more drugs (or other therapeutic agents) are administered for a single disease. For example, in May 2022, the Switzerland-based health organization, F. Hoffmann-La Roche AG, launched PHESGO. This innovative breast cancer treatment, PHESGO, is the pioneering fixed-dose formulation in oncology that combines two monoclonal antibodies, Perjeta (pertuzumab) and Herceptin (trastuzumab), with hyaluronidase. This is given through subcutaneous injections along with intravenous (IV) chemotherapy to manage both early and metastatic breast cancer.
Order Now for Fast Delivery of Your Breast Cancer Monoclonal Antibodies Market Report!
What Regions Are Steering Growth in the Breast Cancer Monoclonal Antibodies Sector?
North America was the largest region in the breast cancer monoclonal antibodies market in 2023. The regions covered in the breast cancer monoclonal antibodies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The Breast Cancer Monoclonal Antibodies Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the breast cancer monoclonal antibodies market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Breast Cancer Monoclonal Antibodies Market Include
1. Breast Cancer Monoclonal Antibodies Market Executive Summary
2. Breast Cancer Monoclonal Antibodies Market Segments
3. Breast Cancer Monoclonal Antibodies Market Size And Template Market Growth Rate
4. Key Breast Cancer Monoclonal Antibodies Market Trends
5. Major Breast Cancer Monoclonal Antibodies Market Drivers
……
25. Key Mergers And Acquisitions In The Breast Cancer Monoclonal Antibodies Market
26. Top Breast Cancer Monoclonal Antibodies Companies
27. Breast Cancer Monoclonal Antibodies Market Opportunities And Strategies
28. Breast Cancer Monoclonal Antibodies Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Cancer Biologics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report
Breast Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report
Antibody Drug Conjugates Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
